Erectile Rating During the Treatment of Rectal Cancers Localized — METEORR  

Rectal Cancer Stage I Clinical Trial

Official title: Erectile Rating During the Treatment of Rectal Cancers Localized. Exploratory Study

Status Terminated

Clinical Trial Summary

Erectile dysfunction will be explored by recording R / P and self-administered questionnaire IIEF-5.

Clinical Trial Description

Erectile dysfunction will be explored by recording R / P and self-administered questionnaire IIEF-5. This dual evaluation will be made before the beginning of the therapeutic treatment and 3 months and 12 months after surgery. Assessed by IIEF-5 will be made only 6, 18 and 24 months after surgery. There will be no changes made to support oncology patients. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Rectal Cancer Stage I
• Rectal Neoplasms

• NCT number: NCT01843218
• Study type: Interventional
• Source: Institut Bergonié
• Status: Terminated
• Phase: N/A
• Start date: March 2008
• Completion date: December 2015